BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29507304)

  • 1. Observation of optic disc neovascularization using OCT angiography in proliferative diabetic retinopathy after intravitreal conbercept injections.
    Zhang X; Wu C; Zhou LJ; Dai RP
    Sci Rep; 2018 Mar; 8(1):3972. PubMed ID: 29507304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal bevacizumab (Avastin) and panretinal photocoagulation in the treatment of high-risk proliferative diabetic retinopathy.
    Yang CS; Hung KC; Huang YM; Hsu WM
    J Ocul Pharmacol Ther; 2013; 29(6):550-5. PubMed ID: 23495932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of aqueous humor levels of PlGF and VEGF in proliferative diabetic retinopathy before and after intravitreal conbercept injection.
    Zhang X; Wu J; Wu C; Bian AL; Geng S; Dai RP
    Diabetes Res Clin Pract; 2020 Apr; 162():108083. PubMed ID: 32057965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor concentration in vitreous humor of patients with severe proliferative diabetic retinopathy after intravitreal injection of conbercept as an adjunctive therapy for vitrectomy.
    Li B; Li MD; Ye JJ; Chen Z; Guo ZJ; Di Y
    Chin Med J (Engl); 2020 Mar; 133(6):664-669. PubMed ID: 32068603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OCT angiography-based monitoring of neovascular regression on fibrovascular membrane after preoperative intravitreal conbercept injection.
    Hu Z; Su Y; Xie P; Chen L; Ji J; Feng T; Wu S; Liang K; Liu Q
    Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1611-1619. PubMed ID: 31053944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observation of neovascularization of the disc associated with proliferative diabetic retinopathy using OCT angiography.
    Akiyama H; Li D; Shimoda Y; Matsumoto H; Kishi S
    Jpn J Ophthalmol; 2018 May; 62(3):286-291. PubMed ID: 29460018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Observation of total VEGF level in hyperglycemic mouse eyes after intravitreal injection of the novel anti-VEGF drug conbercept.
    Du L; Peng H; Wu Q; Zhu M; Luo D; Ke X; Yang P; Lei B
    Mol Vis; 2015; 21():185-93. PubMed ID: 25737631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in Retinal Nerve Fiber Layer Thickness after Multiple Injections of Novel VEGF Decoy Receptor Conbercept for Various Retinal Diseases.
    Zhang Z; Yang X; Jin H; Qu Y; Zhang Y; Liu K; Xu X
    Sci Rep; 2016 Dec; 6():38326. PubMed ID: 27922068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal neovascular changes on optical coherence tomography angiography in proliferative diabetic retinopathy treated with panretinal photocoagulation alone versus with intravitreal conbercept plus panretinal photocoagulation: a pilot study.
    He F; Yu W
    Eye (Lond); 2020 Aug; 34(8):1413-1418. PubMed ID: 31719675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. INTRAVITREAL CONBERCEPT (KH902) FOR SURGICAL TREATMENT OF SEVERE PROLIFERATIVE DIABETIC RETINOPATHY.
    Su L; Ren X; Wei H; Zhao L; Zhang X; Liu J; Su C; Tan L; Li X
    Retina; 2016 May; 36(5):938-43. PubMed ID: 26630313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of conbercept combined with panretinal photocoagulation in the treatment of proliferative diabetic retinopathy.
    He F; Yang J; Zhang X; Yu W
    Sci Rep; 2020 May; 10(1):8778. PubMed ID: 32472048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of Retinal Neovascularization in Proliferative Diabetic Retinopathy Imaged by Optical Coherence Tomography Angiography.
    Ishibazawa A; Nagaoka T; Yokota H; Takahashi A; Omae T; Song YS; Takahashi T; Yoshida A
    Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6247-6255. PubMed ID: 27849310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topographical Response of Retinal Neovascularization to Aflibercept or Panretinal Photocoagulation in Proliferative Diabetic Retinopathy: Post Hoc Analysis of the CLARITY Randomized Clinical Trial.
    Halim S; Nugawela M; Chakravarthy U; Peto T; Madhusudhan S; Lenfestey P; Hamill B; Zheng Y; Parry D; Nicholson L; Greenwood J; Sivaprasad S
    JAMA Ophthalmol; 2021 May; 139(5):501-507. PubMed ID: 33704351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranibizumab Plus Panretinal Photocoagulation versus Panretinal Photocoagulation Alone for High-Risk Proliferative Diabetic Retinopathy (PROTEUS Study).
    Figueira J; Fletcher E; Massin P; Silva R; Bandello F; Midena E; Varano M; Sivaprasad S; Eleftheriadis H; Menon G; Amaro M; Ayello Scheer S; Creuzot-Garcher C; Nascimento J; Alves D; Nunes S; Lobo C; Cunha-Vaz J;
    Ophthalmology; 2018 May; 125(5):691-700. PubMed ID: 29395119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.
    Avery RL; Pearlman J; Pieramici DJ; Rabena MD; Castellarin AA; Nasir MA; Giust MJ; Wendel R; Patel A
    Ophthalmology; 2006 Oct; 113(10):1695.e1-15. PubMed ID: 17011951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated intravitreal bevacizumab (Avastin(®)) treatment of persistent new vessels in proliferative diabetic retinopathy after complete panretinal photocoagulation.
    Schmidinger G; Maar N; Bolz M; Scholda C; Schmidt-Erfurth U
    Acta Ophthalmol; 2011 Feb; 89(1):76-81. PubMed ID: 21272288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal conbercept improves outcome of proliferative diabetic retinopathy through inhibiting inflammation and oxidative stress.
    Xia JP; Liu SQ; Wang S
    Life Sci; 2021 Jan; 265():118795. PubMed ID: 33227274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. INTRAVITREAL BEVACIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Results From the Pan-American Collaborative Retina Study Group (PACORES) at 24 Months of Follow-up.
    Arevalo JF; Lasave AF; Wu L; Maia M; Diaz-Llopis M; Alezzandrini AA; Brito M;
    Retina; 2017 Feb; 37(2):334-343. PubMed ID: 27429384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 12-month therapeutic effect of conbercept and ranibizumab for diabetic macular edema: a real-life clinical practice study.
    Xu Y; Rong A; Xu W; Niu Y; Wang Z
    BMC Ophthalmol; 2017 Aug; 17(1):158. PubMed ID: 28841827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-Dose Intravitreal Conbercept before Panretinal Photocoagulation as an Effective Adjunctive Treatment in Chinese Proliferative Diabetic Retinopathy.
    Zhang Q; Zhang T; Zhuang H; Sun Z; Qin Y
    Ophthalmologica; 2019; 242(2):59-68. PubMed ID: 30699427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.